OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $19.844 million which beat the analyst consensus estimate of $18.353 million by 8.12 percent. This is a 9.50 percent decrease over sales of $21.928 million the same period last year.